FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1683 May 27, 1999 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Pomerantz, R. J. PubMed Citation

To the Editor: Eradication of the human immunodeficiency virus (HIV) is a difficult goal to achieve, because a reservoir of replication-competent HIV is established in resting CD4 T lymphocytes soon after infection and persists after years of highly active antiretroviral treatment.¹ A more realistic alternative to lifelong cumbersome, toxic, and expensive treatments is to control HIV, as occurs in patients with long-term nonprogression of the disease.

A patient, who has become known as "the Berlin patient," was treated soon after acute HIV infection, before complete seroconversion on Western blotting, with a combination of hydroxyurea (400 mg three times daily),² didanosine . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Calarota, S. A., Foli, A., Maserati, R., Baldanti, F., Paolucci, S., Young, M. A., Tsoukas, C. M., Lisziewicz, J., Lori, F. (2008). HIV-1-Specific T Cell Precursors with High Proliferative Capacity Correlate with Low Viremia and High CD4 Counts in Untreated Individuals. J. Immunol. 180: 5907-5915 [Abstract] [Full Text]  
• Pastori, C., Clivio, A., Diomede, L., Consonni, R., De Mori, G. M. S., Longhi, R., Colombo, G., Lopalco, L. (2008). Two Amino Acid Substitutions within the First External Loop of CCR5 Induce Human Immunodeficiency Virus-Blocking Antibodies in Mice and Chickens. J. Virol. 82: 4125-4134 [Abstract] [Full Text]  
• Mehandru, S., Vcelar, B., Wrin, T., Stiegler, G., Joos, B., Mohri, H., Boden, D., Galovich, J., Tenner-Racz, K., Racz, P., Carrington, M., Petropoulos, C., Katinger, H., Markowitz, M. (2007). Adjunctive Passive Immunotherapy in Human Immunodeficiency Virus Type 1-Infected Individuals Treated with Antiviral Therapy during Acute and Early Infection. J. Virol. 81: 11016-11031 [Abstract] [Full Text]  
• von Gegerfelt, A. S., Rosati, M., Alicea, C., Valentin, A., Roth, P., Bear, J., Franchini, G., Albert, P. S., Bischofberger, N., Boyer, J. D., Weiner, D. B., Markham, P., Israel, Z. R., Eldridge, J. H., Pavlakis, G. N., Felber, B. K. (2007). Long-Lasting Decrease in Viremia in Macaques Chronically Infected with Simian Immunodeficiency Virus SIVmac251 after Therapeutic DNA Immunization. J. Virol. 81: 1972-1979 [Abstract] [Full Text]  
• Bongiovanni, M., Casana, M., Tincati, C., Monforte, A. d. (2006). Treatment interruptions in HIV-infected subjects. J Antimicrob Chemother 58: 502-505 [Abstract] [Full Text]  
• Van Rompay, K. K. A., Singh, R. P., Heneine, W., Johnson, J. A., Montefiori, D. C., Bischofberger, N., Marthas, M. L. (2006). Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques.. J. Virol. 80: 6399-6410 [Abstract] [Full Text]  
• Wirden, M., Delaugerre, C., Marcelin, A. G., Ktorza, N., Ait Mohand, H., Dominguez, S., Schneider, L., Ghosn, J., Pauchard, M., Costagliola, D., Katlama, C., Calvez, V. (2004). Comparison of the Dynamics of Resistance-Associated Mutations to Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Protease Inhibitors after Cessation of Antiretroviral Combination Therapy. Antimicrob. Agents Chemother. 48: 644-647 [Abstract] [Full Text]  
• Fagard, C., Oxenius, A., Gunthard, H., Garcia, F., Le Braz, M., Mestre, G., Battegay, M., Furrer, H., Vernazza, P., Bernasconi, E., Telenti, A., Weber, R., Leduc, D., Yerly, S., Price, D., Dawson, S. J., Klimkait, T., Perneger, T. V., McLean, A., Clotet, B., Gatell, J. M., Perrin, L., Plana, M., Phillips, R., Hirschel, B. (2003). A Prospective Trial of Structured Treatment Interruptions in Human Immunodeficiency Virus Infection. Arch Intern Med 163: 1220-1226 [Abstract] [Full Text]  
• Cheng, L. E., Greenberg, P. D. (2002). Selective Delivery of Augmented IL-2 Receptor Signals to Responding CD8+ T Cells Increases the Size of the Acute Antiviral Response and of the Resulting Memory T Cell Pool. J. Immunol. 169: 4990-4997 [Abstract] [Full Text]  
• Tryniszewska, E., Nacsa, J., Lewis, M. G., Silvera, P., Montefiori, D., Venzon, D., Hel, Z., Parks, R. W., Moniuszko, M., Tartaglia, J., Smith, K. A., Franchini, G. (2002). Vaccination of Macaques with Long-Standing SIVmac251 Infection Lowers the Viral Set Point After Cessation of Antiretroviral Therapy. J. Immunol. 169: 5347-5357 [Abstract] [Full Text]  
• Oxenius, A., Price, D. A., Gunthard, H. F., Dawson, S. J., Fagard, C., Perrin, L., Fischer, M., Weber, R., Plana, M., Garcia, F., Hirschel, B., McLean, A., Phillips, R. E. (2002). Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection. Proc. Natl. Acad. Sci. USA 99: 13747-13752 [Abstract] [Full Text]  
• Kane, B. (2002). Chronic HIV Infection: Can Anyone Afford a Drug Holiday?. ANN INTERN MED 137: 301-304 [Full Text]  
• Walmsley, S., Loutfy, M. (2002). Can Structured Treatment Interruptions (STIs) Be Used as a Strategy to Decrease Total Drug Requirements and Toxicity in HIV Infection?. J Int Assoc Physicians AIDS Care (Chic Ill) 1: 95-103 [Abstract]  
• Sarkar, S., Kalia, V., Murphey-Corb, M., Montelaro, R. C. (2002). Detailed Analysis of CD4+ Th Responses to Envelope and Gag Proteins of Simian Immunodeficiency Virus Reveals an Exclusion of Broadly Reactive Th Epitopes from the Glycosylated Regions of Envelope. J. Immunol. 168: 4001-4011 [Abstract] [Full Text]  
• Lori, F., Lisziewicz, J. (2001). Structured Treatment Interruptions for the Management of HIV Infection. JAMA 286: 2981-2987 [Abstract] [Full Text]  
• Pacanowski, J., Kahi, S., Baillet, M., Lebon, P., Deveau, C., Goujard, C., Meyer, L., Oksenhendler, E., Sinet, M., Hosmalin, A. (2001). Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 98: 3016-3021 [Abstract] [Full Text]  
• Montefiori, D. C., Hill, T. S., Vo, H. T. T., Walker, B. D., Rosenberg, E. S. (2001). Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 Infection. J. Virol. 75: 10200-10207 [Abstract] [Full Text]  
• Munch, J., Stolte, N., Fuchs, D., Stahl-Hennig, C., Kirchhoff, F. (2001). Efficient Class I Major Histocompatibility Complex Down-Regulation by Simian Immunodeficiency Virus Nef Is Associated with a Strong Selective Advantage in Infected Rhesus Macaques. J. Virol. 75: 10532-10536 [Abstract] [Full Text]  
• Ortiz, G. M., Wellons, M., Brancato, J., Vo, H. T. T., Zinn, R. L., Clarkson, D. E., Van Loon, K., Bonhoeffer, S., Miralles, G. D., Montefiori, D., Bartlett, J. A., Nixon, D. F. (2001). Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc. Natl. Acad. Sci. USA 10.1073/pnas.221452198v1 [Abstract] [Full Text]  
• Lisziewicz, J., Gabrilovich, D. I., Varga, G., Xu, J., Greenberg, P. D., Arya, S. K., Bosch, M., Behr, J.-P., Lori, F. (2001). Induction of Potent Human Immunodeficiency Virus Type 1-Specific T-Cell-Restricted Immunity by Genetically Modified Dendritic Cells. J. Virol. 75: 7621-7628 [Abstract] [Full Text]  
• Hogan, C. M., Hammer, S. M. (2001). Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics. ANN INTERN MED 134: 978-996 [Abstract] [Full Text]  
• Altfeld, M., Rosenberg, E. S., Shankarappa, R., Mukherjee, J. S., Hecht, F. M., Eldridge, R. L., Addo, M. M., Poon, S. H., Phillips, M. N., Robbins, G. K., Sax, P. E., Boswell, S., Kahn, J. O., Brander, C., Goulder, P. J.R., Levy, J. A., Mullins, J. I., Walker, B. D. (2001). Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection. JEM 193: 169-180 [Abstract] [Full Text]  
• Carcelain, G., Tubiana, R., Samri, A., Calvez, V., Delaugerre, C., Agut, H., Katlama, C., Autran, B. (2001). Transient Mobilization of Human Immunodeficiency Virus (HIV)-Specific CD4 T-Helper Cells Fails To Control Virus Rebounds during Intermittent Antiretroviral Therapy in Chronic HIV Type 1 Infection. J. Virol. 75: 234-241 [Abstract] [Full Text]  
• Lori, F., Lewis, M. G., Xu, J., Varga, G., Zinn Jr., D. E., Crabbs, C., Wagner, W., Greenhouse, J., Silvera, P., Yalley-Ogunro, J., Tinelli, C., Lisziewicz, J. (2000). Control of SIV Rebound Through Structured Treatment Interruptions During Early Infection. Science 290: 1591-1593 [Abstract] [Full Text]  
• Bartlett, J. G. (2000). Update in Infectious Diseases. ANN INTERN MED 133: 285-292 [Full Text]  
• Mollet, L., Li, T.-S., Samri, A., Tournay, C., Tubiana, R., Calvez, V., Debre, P., Katlama, C., Autran, B. (2000). Dynamics of HIV-Specific CD8+ T Lymphocytes with Changes in Viral Load. J. Immunol. 165: 1692-1704 [Abstract] [Full Text]  
• Wodarz, D., Nowak, M. A. (2000). HIV therapy: Managing resistance. Proc. Natl. Acad. Sci. USA 97: 8193-8195 [Full Text]  
• Lechner, F., Wong, D. K.H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., Walker, B. D. (2000). Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus. JEM 191: 1499-1512 [Abstract] [Full Text]  
• Wodarz, D., May, R. M., Nowak, M. A. (2000). The role of antigen-independent persistence of memory cytotoxic T lymphocytes. Int Immunol 12: 467-477 [Abstract] [Full Text]  
• Lifson, J. D., Rossio, J. L., Arnaout, R., Li, L., Parks, T. L., Schneider, D. K., Kiser, R. F., Coalter, V. J., Walsh, G., Imming, R. J., Fisher, B., Flynn, B. M., Bischofberger, N., Piatak, M. Jr., Hirsch, V. M., Nowak, M. A., Wodarz, D. (2000). Containment of Simian Immunodeficiency Virus Infection: Cellular Immune Responses and Protection from Rechallenge following Transient Postinoculation Antiretroviral Treatment. J. Virol. 74: 2584-2593 [Abstract] [Full Text]  
• Rosenwirth, B., ten Haaft, P., Bogers, W. M. J. M., Nieuwenhuis, I. G., Niphuis, H., Kuhn, E.-M., Bischofberger, N., Heeney, J. L., Überla, K. (2000). Antiretroviral Therapy during Primary Immunodeficiency Virus Infection Can Induce Persistent Suppression of Virus Load and Protection from Heterologous Challenge in Rhesus Macaques. J. Virol. 74: 1704-1711 [Abstract] [Full Text]  
• Davey, R. T. Jr., Bhat, N., Yoder, C., Chun, T.-W., Metcalf, J. A., Dewar, R., Natarajan, V., Lempicki, R. A., Adelsberger, J. W., Miller, K. D., Kovacs, J. A., Polis, M. A., Walker, R. E., Falloon, J., Masur, H., Gee, D., Baseler, M., Dimitrov, D. S., Fauci, A. S., Lane, H. C. (1999). HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl. Acad. Sci. USA 96: 15109-15114 [Abstract] [Full Text]  
• Wodarz, D., Nowak, M. A. (1999). Specific therapy regimes could lead to long-term immunological control of HIV. Proc. Natl. Acad. Sci. USA 96: 14464-14469 [Abstract] [Full Text]  
• Dornadula, G., Zhang, H., VanUitert, B., Stern, J., Livornese, L. Jr, Ingerman, M. J., Witek, J., Kedanis, R. J., Natkin, J., DeSimone, J., Pomerantz, R. J. (1999). Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral Therapy. JAMA 282: 1627-1632 [Abstract] [Full Text]  
• D'Aquila, R., Walker, B. (1999). Exploring the Benefits and Limits of Highly Active Antiretroviral Therapy. JAMA 282: 1668-1669 [Full Text]  
• (1999). Stopping Antiretroviral Therapy Means Viral Rebound . . . Usually. AIDS Clin Care 1999: 4-4 [Full Text]  
• Pomerantz, R. J. (1999). Residual HIV-1 Disease in the Era of Highly Active Antiretroviral Therapy. NEJM 340: 1672-1674 [Full Text]  
• Flores-Villanueva, P. O., Yunis, E. J., Delgado, J. C., Vittinghoff, E., Buchbinder, S., Leung, J. Y., Uglialoro, A. M., Clavijo, O. P., Rosenberg, E. S., Kalams, S. A., Braun, J. D., Boswell, S. L., Walker, B. D., Goldfeld, A. E. (2001). Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc. Natl. Acad. Sci. USA 98: 5140-5145 [Abstract] [Full Text]  
• Ortiz, G. M., Wellons, M., Brancato, J., Vo, H. T. T., Zinn, R. L., Clarkson, D. E., Van Loon, K., Bonhoeffer, S., Miralles, G. D., Montefiori, D., Bartlett, J. A., Nixon, D. F. (2001). Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects. Proc. Natl. Acad. Sci. USA 98: 13288-13293 [Abstract] [Full Text]